Gan & Lee Pharmaceuticals. (SHA:603087)
China flag China · Delayed Price · Currency is CNY
65.75
-0.35 (-0.53%)
At close: Feb 6, 2026

SHA:603087 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,064902.782,4432,8903,3062,825
Short-Term Investments
---201.36276.44945.34
Trading Asset Securities
1,1021,5002,4101,6361,624787.05
Cash & Short-Term Investments
3,1662,4034,8534,7285,2064,557
Cash Growth
-37.51%-50.48%2.66%-9.20%14.24%161.44%
Accounts Receivable
529.63213.71383.74189.57934.66827.35
Other Receivables
29.0131.891.630.990.160.96
Receivables
558.64245.6385.37190.55934.82828.3
Inventory
1,1251,053860.51648.65651.33493.48
Other Current Assets
118.589.0776.7397.3677.9580.55
Total Current Assets
4,9683,7916,1765,6646,8705,960
Property, Plant & Equipment
3,8243,8823,8863,6612,5952,149
Long-Term Investments
508.15497.03304.6630201.36466.05
Other Intangible Assets
263.73273.06278.08293.48295.99238.92
Long-Term Deferred Tax Assets
228.78206.94168.95138.2530.814.93
Long-Term Deferred Charges
1,399924.91821.97743.19588.87544.27
Other Long-Term Assets
951.052,46879.9976.51270.33134.67
Total Assets
12,14312,04311,71510,60710,8539,507
Accounts Payable
126.49115.6194.8236.5226.1514.79
Accrued Expenses
168.73183.44192.54190173.04183.07
Current Portion of Leases
-1.332.185.695.07-
Current Income Taxes Payable
15.861.491.421.35106.3253.35
Current Unearned Revenue
49.1163.2552.9968.1336.5668.44
Other Current Liabilities
330.27436429.49511.36138.3990.19
Total Current Liabilities
690.46801.13773.45813.04485.53409.85
Long-Term Leases
2.583.315.458.3312.17-
Long-Term Unearned Revenue
164.68168.92179.63187.63141.98125.77
Long-Term Deferred Tax Liabilities
-12.11--36.1531.78
Other Long-Term Liabilities
2.652.971412.2710.21.69
Total Liabilities
860.37988.45972.521,021686.02569.09
Common Stock
597.3601.07594.16565.65561.54561.54
Additional Paid-In Capital
3,5223,5913,3512,5632,4762,474
Retained Earnings
7,2807,0596,8656,5257,1335,905
Treasury Stock
-120.69-200.85-71.36-71.36--
Comprehensive Income & Other
3.634.043.823.44-3.44-1.55
Total Common Equity
11,28211,05410,7439,58610,1678,939
Minority Interest
--0-0.16-0.16-0.16
Shareholders' Equity
11,28211,05410,7439,58610,1678,938
Total Liabilities & Equity
12,14312,04311,71510,60710,8539,507
Total Debt
2.584.647.6214.0117.24-
Net Cash (Debt)
3,1642,3994,8464,7145,1894,557
Net Cash Growth
-37.52%-50.50%2.80%-9.16%13.86%161.44%
Net Cash Per Share
5.384.068.558.379.258.55
Filing Date Shares Outstanding
595.31598.96590.05561.54561.54561.54
Total Common Shares Outstanding
595.31598.96590.05561.54561.54561.54
Working Capital
4,2782,9905,4024,8516,3855,550
Book Value Per Share
18.9518.4618.2117.0718.1115.92
Tangible Book Value
11,01910,78110,4649,2929,8718,700
Tangible Book Value Per Share
18.5118.0017.7316.5517.5815.49
Buildings
-2,1371,3441,1651,0461,013
Machinery
-1,6011,4431,2371,2631,171
Construction In Progress
-1,2622,0072,003874.91410.12
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.